XML 34 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Incentive Plans and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity for the period ended March 31, 2024 was as follows (in thousands, except share and per share data and years):

 

 

 

Options

 

 

Weighted-Average
Exercise
Price per Share

 

 

Weighted-Average
Remaining
Contractual Term

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2023

 

 

8,276,442

 

 

$

10.07

 

 

 

8.3

 

 

$

40,420

 

Granted

 

 

169,500

 

 

$

19.93

 

 

 

 

 

 

 

Exercised

 

 

(92,280

)

 

$

1.81

 

 

 

 

 

 

 

Cancelled

 

 

(6,163

)

 

$

13.64

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

8,347,499

 

 

$

10.36

 

 

 

8.1

 

 

$

56,838

 

Exercisable at March 31, 2024

 

 

3,657,819

 

 

$

8.60

 

 

 

7.4

 

 

$

32,237

 

Vested and expected to vest as of March 31, 2024

 

 

8,347,499

 

 

$

10.36

 

 

 

8.1

 

 

$

56,838

 

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The fair value of stock options was estimated using the following assumptions:

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

2023

 

Risk-free rate of interest

 

4.2%

 

3.5 - 4.2%

 

Expected term (years)

 

6.0 - 6.1

 

6.0 - 6.1

 

Expected stock price volatility

 

88.6%

 

89.2 - 89.7 %

 

Dividend yield

 

 

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense recognized for all equity awards has been reported in the condensed statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Research and development expense

 

$

2,475

 

 

$

1,460

 

General and administrative expense

 

 

1,640

 

 

 

973

 

Total

 

$

4,115

 

 

$

2,433